282 related articles for article (PubMed ID: 30117406)
1. Choline-PET/CT in the Differential Diagnosis Between Cystic Glioblastoma and Intraparenchymal Hemorrhage.
Alongi P; Vetrano IG; Fiasconaro E; Alaimo V; Laudicella R; Bellavia M; Rubino F; Bagnato S; Galardi G
Curr Radiopharm; 2019; 12(1):88-92. PubMed ID: 30117406
[TBL] [Abstract][Full Text] [Related]
2. Promising role of [18F] fluorocholine PET/CT vs [18F] fluorodeoxyglucose PET/CT in primary brain tumors-early experience.
Lam WW; Ng DC; Wong WY; Ong SC; Yu SW; See SJ
Clin Neurol Neurosurg; 2011 Feb; 113(2):156-61. PubMed ID: 21036467
[TBL] [Abstract][Full Text] [Related]
3. A Dual Tracer 18F-FCH/18F-FDG PET Imaging of an Orthotopic Brain Tumor Xenograft Model.
Fu Y; Ong LC; Ranganath SH; Zheng L; Kee I; Zhan W; Yu S; Chow PK; Wang CH
PLoS One; 2016; 11(2):e0148123. PubMed ID: 26844770
[TBL] [Abstract][Full Text] [Related]
4. 18F-FET and 18F-choline PET-CT in patients with MRI-suspected low-grade gliomas: a pilot study.
Mišir Krpan A; Hodolič M; Golubić AT; Baučić M; Nemir J; Mrak G; Žuvić M; Huić D
Croat Med J; 2021 Aug; 62(4):310-317. PubMed ID: 34472733
[TBL] [Abstract][Full Text] [Related]
5. 18F-fluorocholine versus 18F-fluorodeoxyglucose for PET/CT imaging in patients with suspected relapsing or progressive multiple myeloma: a pilot study.
Cassou-Mounat T; Balogova S; Nataf V; Calzada M; Huchet V; Kerrou K; Devaux JY; Mohty M; Talbot JN; Garderet L
Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):1995-2004. PubMed ID: 27121691
[TBL] [Abstract][Full Text] [Related]
6. Evidence of 18F-FCH Uptake in Human T98G Glioblastoma Cells.
Buroni FE; Pasi F; Persico MG; Lodola L; Aprile C; Nano R
Anticancer Res; 2015 Dec; 35(12):6439-43. PubMed ID: 26637854
[TBL] [Abstract][Full Text] [Related]
7. Impact of 18F-choline PET/CT in prostate cancer patients with biochemical recurrence: influence of androgen deprivation therapy and correlation with PSA kinetics.
Beheshti M; Haim S; Zakavi R; Steinmair M; Waldenberger P; Kunit T; Nader M; Langsteger W; Loidl W
J Nucl Med; 2013 Jun; 54(6):833-40. PubMed ID: 23559588
[TBL] [Abstract][Full Text] [Related]
8. Baseline and Post-treatment 18F-Fluorocholine PET/CT Predicts Outcomes in Hepatocellular Carcinoma Following Locoregional Therapy.
Wallace MC; Sek K; Francis RJ; Samuelson S; Ferguson J; Tibballs J; Asad A; Preen DB; MacQuillan G; Garas G; Adams LA; Jeffrey GP
Dig Dis Sci; 2020 Feb; 65(2):647-657. PubMed ID: 31440998
[TBL] [Abstract][Full Text] [Related]
9. The usefulness of 18F-fluorocholine PET/CT in the detection of recurrence of central nervous system primary neoplasms.
Montes A; Fernández A; Camacho V; de Quintana C; Gallego O; Craven-Bartle J; López D; Molet J; Gómez-Ansón B; Carrió I
Rev Esp Med Nucl Imagen Mol; 2017; 36(4):227-232. PubMed ID: 28219644
[TBL] [Abstract][Full Text] [Related]
10. Utilizing 18F-fluoroethyltyrosine (FET) positron emission tomography (PET) to define suspected nonenhancing tumor for radiation therapy planning of glioblastoma.
Hayes AR; Jayamanne D; Hsiao E; Schembri GP; Bailey DL; Roach PJ; Khasraw M; Newey A; Wheeler HR; Back M
Pract Radiat Oncol; 2018; 8(4):230-238. PubMed ID: 29730279
[TBL] [Abstract][Full Text] [Related]
11. Combined use of F-18 fluorocholine positron emission tomography and magnetic resonance spectroscopy for brain tumor evaluation.
Kwee SA; Coel MN; Lim J; Ko JP
J Neuroimaging; 2004 Jul; 14(3):285-9. PubMed ID: 15228773
[TBL] [Abstract][Full Text] [Related]
12. 18F-Fluorocholine PET/CT Complementing the Role of Dynamic Contrast-Enhanced MRI for Providing Comprehensive Diagnostic Workup in Prostate Cancer Patients With Suspected Relapse Following Radical Prostatectomy.
Vadi SK; Singh B; Basher RK; Watts A; Sood AK; Lal A; Kakkar N; Singh SK
Clin Nucl Med; 2017 Aug; 42(8):e355-e361. PubMed ID: 28525448
[TBL] [Abstract][Full Text] [Related]
13. Is 18F-fluorocholine-positron emission tomography/computerized tomography a new imaging tool for detecting hyperfunctioning parathyroid glands in primary or secondary hyperparathyroidism?
Michaud L; Burgess A; Huchet V; Lefèvre M; Tassart M; Ohnona J; Kerrou K; Balogova S; Talbot JN; Périé S
J Clin Endocrinol Metab; 2014 Dec; 99(12):4531-6. PubMed ID: 25215560
[TBL] [Abstract][Full Text] [Related]
14. Comparison of meta-analyses among elastosonography (ES) and positron emission tomography/computed tomography (PET/CT) imaging techniques in the application of prostate cancer diagnosis.
Ouyang Q; Duan Z; Lei J; Jiao G
Tumour Biol; 2016 Mar; 37(3):2999-3007. PubMed ID: 26415734
[TBL] [Abstract][Full Text] [Related]
15. Comparison of
Palard-Novello X; Beuzit L; Gambarota G; Le Jeune F; Garin E; Salaün PY; Devillers A; Querellou S; Bourguet P; Saint-Jalmes H
Ann Nucl Med; 2019 Jan; 33(1):47-54. PubMed ID: 30219990
[TBL] [Abstract][Full Text] [Related]
16. The ability of 18F-choline PET/CT to identify local recurrence of prostate cancer.
Evangelista L; Cimitan M; Hodolič M; Baseric T; Fettich J; Borsatti E
Abdom Imaging; 2015 Oct; 40(8):3230-7. PubMed ID: 26428685
[TBL] [Abstract][Full Text] [Related]
17. Whole-body 18F-fluorocholine (FCH) PET/CT and MRI of the spine for monitoring patients with castration-resistant prostate cancer metastatic to bone: a pilot study.
Balogova S; Zakoun JB; Michaud L; Khalil A; Tassart M; Esteso A; Kerrou K; Huchet V; Carette MF; Lotz JP; Talbot JN
Clin Nucl Med; 2014 Nov; 39(11):951-9. PubMed ID: 25140552
[TBL] [Abstract][Full Text] [Related]
18. Is It Possible to Establish the Extent of Resection of Glioblastoma With 18F-Fluorocholine PET/CT?
García Vicente AM; Perez-Beteta J; Calvo García M; Villena Martín M; Soriano Castrejón A
Clin Nucl Med; 2018 Aug; 43(8):e269-e273. PubMed ID: 29894332
[TBL] [Abstract][Full Text] [Related]
19.
Kanoun S; Walker P; Vrigneaud JM; Depardon E; Barbier V; Humbert O; Moulin M; Créhange G; Cormier L; Loffroy R; Brunotte F; Cochet A
Int J Radiat Oncol Biol Phys; 2017 Apr; 97(5):986-994. PubMed ID: 28333020
[TBL] [Abstract][Full Text] [Related]
20. Pairwise comparison of 18F-FDG and 18F-FCH PET/CT in prostate cancer patients with rising PSA and known or suspected second malignancy.
How Kit N; Dugué AE; Sevin E; Allouache N; Lesaunier F; Joly F; Aide N
Nucl Med Commun; 2016 Apr; 37(4):348-55. PubMed ID: 26642435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
